HUE035393T2 - Procedures and preparations for the treatment of HIV-related diarrhea - Google Patents
Procedures and preparations for the treatment of HIV-related diarrhea Download PDFInfo
- Publication number
- HUE035393T2 HUE035393T2 HUE11837249A HUE11837249A HUE035393T2 HU E035393 T2 HUE035393 T2 HU E035393T2 HU E11837249 A HUE11837249 A HU E11837249A HU E11837249 A HUE11837249 A HU E11837249A HU E035393 T2 HUE035393 T2 HU E035393T2
- Authority
- HU
- Hungary
- Prior art keywords
- crofelemer
- patient
- diarrhea
- daily
- day
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40862210P | 2010-10-31 | 2010-10-31 | |
| US40933510P | 2010-11-02 | 2010-11-02 | |
| US41624910P | 2010-11-22 | 2010-11-22 | |
| US201161434379P | 2011-01-19 | 2011-01-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE035393T2 true HUE035393T2 (en) | 2018-05-02 |
Family
ID=45994461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE11837249A HUE035393T2 (en) | 2010-10-31 | 2011-10-31 | Procedures and preparations for the treatment of HIV-related diarrhea |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US8962680B2 (https=) |
| EP (1) | EP2632550B1 (https=) |
| JP (2) | JP6063385B2 (https=) |
| CN (2) | CN107595836A (https=) |
| AU (1) | AU2011320155B2 (https=) |
| BR (1) | BR112013010774A2 (https=) |
| CA (1) | CA2816416C (https=) |
| DK (1) | DK2632550T3 (https=) |
| EC (1) | ECSP13012650A (https=) |
| ES (1) | ES2635435T3 (https=) |
| HK (1) | HK1249036A1 (https=) |
| HU (1) | HUE035393T2 (https=) |
| MX (1) | MX348184B (https=) |
| PE (1) | PE20140036A1 (https=) |
| PH (1) | PH12013500857A1 (https=) |
| PL (1) | PL2632550T3 (https=) |
| PT (1) | PT2632550T (https=) |
| RU (1) | RU2597746C2 (https=) |
| WO (1) | WO2012058664A1 (https=) |
| ZA (1) | ZA201303136B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2241318T1 (sl) | 2006-05-01 | 2013-04-30 | Napo Pharmaceuticals, Inc. | Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo |
| ES2616012T3 (es) | 2006-05-01 | 2017-06-09 | Napo Pharmaceuticals, Inc. | Composiciones para tratar o prevenir enfermedad inflamatoria del intestino |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| CN107595836A (zh) | 2010-10-31 | 2018-01-19 | 纳珀制药公司 | 用于治疗hiv相关性腹泻的方法和组合物 |
| EP2928560A4 (en) * | 2012-12-07 | 2016-06-01 | Salix Pharmaceuticals Inc | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA |
| US11389424B2 (en) | 2017-03-09 | 2022-07-19 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating chemotherapy-induced diarrhea |
| JP7328153B2 (ja) | 2017-05-31 | 2023-08-16 | ナポ ファーマシューティカルズ インク． | 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物 |
| US11857510B2 (en) | 2017-05-31 | 2024-01-02 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating congenital diarrhea disorder |
| EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
| CA3182864A1 (en) * | 2020-06-19 | 2021-12-23 | Lisa A. CONTE | Methods and compositions for treating chemotherapy-induced diarrhea |
| WO2022115481A1 (en) * | 2020-11-24 | 2022-06-02 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating post-acute infection gastrointestinal disorders |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| EP2060183A3 (en) | 1996-10-16 | 2009-06-03 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| WO2000047062A2 (en) * | 1999-02-01 | 2000-08-17 | Shaman Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
| US20040071793A1 (en) | 2002-10-05 | 2004-04-15 | Bobrowski Paul J. | Oral rehydration methods and compositions |
| WO2005074575A2 (en) * | 2004-01-30 | 2005-08-18 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| JP2008546790A (ja) * | 2005-06-22 | 2008-12-25 | ユニバーシティー オブ マサチューセッツ | Ｈｉｖ−１プロテアーゼ阻害剤 |
| CA2633417A1 (en) | 2005-12-15 | 2007-06-21 | Bayer Healthcare Ag | Diaryl ureas for treating virus infections |
| SI2241318T1 (sl) * | 2006-05-01 | 2013-04-30 | Napo Pharmaceuticals, Inc. | Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo |
| ES2616012T3 (es) | 2006-05-01 | 2017-06-09 | Napo Pharmaceuticals, Inc. | Composiciones para tratar o prevenir enfermedad inflamatoria del intestino |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| US20100092479A1 (en) | 2008-08-18 | 2010-04-15 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
| US7928115B2 (en) | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
| WO2011024049A2 (en) | 2009-08-26 | 2011-03-03 | Glenmark Pharmaceuticals Ltd | Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations |
| AU2010303577B2 (en) | 2009-10-06 | 2015-10-22 | Napo Pharmaceuticals, Inc. | Methods of treating diseases with proanthocyanidin oligomers such as crofelemer |
| US20110087530A1 (en) | 2009-10-09 | 2011-04-14 | Visa U.S.A. Inc. | Systems and Methods to Provide Loyalty Programs |
| CN107595836A (zh) | 2010-10-31 | 2018-01-19 | 纳珀制药公司 | 用于治疗hiv相关性腹泻的方法和组合物 |
| WO2012101008A1 (en) | 2011-01-27 | 2012-08-02 | Glenmark Pharmaceuticals Limited | Process for the production of proanthocyanidin polymeric composition |
| BR112014015314A2 (pt) | 2011-12-22 | 2017-06-13 | Glenmark Pharmaceuticals Ltd | composição farmacêutica não entérica compreendendo crofelemer |
| EP2928560A4 (en) | 2012-12-07 | 2016-06-01 | Salix Pharmaceuticals Inc | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA |
-
2011
- 2011-10-31 CN CN201711077144.7A patent/CN107595836A/zh active Pending
- 2011-10-31 RU RU2013123794/15A patent/RU2597746C2/ru active
- 2011-10-31 CN CN2011800637391A patent/CN103370101A/zh active Pending
- 2011-10-31 JP JP2013536904A patent/JP6063385B2/ja active Active
- 2011-10-31 PE PE2013000926A patent/PE20140036A1/es not_active Application Discontinuation
- 2011-10-31 PT PT118372499T patent/PT2632550T/pt unknown
- 2011-10-31 EP EP11837249.9A patent/EP2632550B1/en active Active
- 2011-10-31 ES ES11837249.9T patent/ES2635435T3/es active Active
- 2011-10-31 DK DK11837249.9T patent/DK2632550T3/en active
- 2011-10-31 CA CA2816416A patent/CA2816416C/en active Active
- 2011-10-31 PL PL11837249T patent/PL2632550T3/pl unknown
- 2011-10-31 WO PCT/US2011/058549 patent/WO2012058664A1/en not_active Ceased
- 2011-10-31 MX MX2013004873A patent/MX348184B/es active IP Right Grant
- 2011-10-31 US US13/285,397 patent/US8962680B2/en active Active
- 2011-10-31 HU HUE11837249A patent/HUE035393T2/en unknown
- 2011-10-31 BR BR112013010774A patent/BR112013010774A2/pt not_active Application Discontinuation
- 2011-10-31 PH PH1/2013/500857A patent/PH12013500857A1/en unknown
- 2011-10-31 AU AU2011320155A patent/AU2011320155B2/en active Active
- 2011-11-11 US US13/294,307 patent/US20120107370A1/en not_active Abandoned
-
2013
- 2013-04-29 ZA ZA2013/03136A patent/ZA201303136B/en unknown
- 2013-05-31 EC ECSP13012650 patent/ECSP13012650A/es unknown
-
2014
- 2014-06-17 US US14/307,175 patent/US20140294903A1/en not_active Abandoned
-
2015
- 2015-01-15 US US14/597,740 patent/US9585868B2/en active Active
-
2016
- 2016-08-02 JP JP2016151656A patent/JP6310971B2/ja active Active
-
2018
- 2018-07-09 HK HK18108819.2A patent/HK1249036A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2632550T3 (en) | METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA | |
| US20140163096A1 (en) | Methods and compositions for treating hiv-associated diarrhea | |
| JP2020510675A (ja) | ミトコンドリア起源のｒｏｓの産生の特異的阻害剤を使用した、薬物誘発ｑｔ間隔延長に関連するリスクの予防 | |
| AU2018275685B2 (en) | Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome | |
| AU2018278312B2 (en) | Methods and compositions for treating congenital diarrhea disorder | |
| CA3235677A1 (en) | Treatment of irritability in subjects with autism spectrum disorders with moderate to severe anxiety and/or social avoidance | |
| HK1183263B (en) | Methods and compositions for treating hiv-associated diarrhea | |
| HK1183263A (en) | Methods and compositions for treating hiv-associated diarrhea | |
| CN112789052A (zh) | 用于保护皮肤免受紫外线辐射的番茄红素组合物和方法 | |
| WO2022115481A1 (en) | Methods and compositions for treating post-acute infection gastrointestinal disorders | |
| D'Arcy | Adverse reactions to excipients in pharmaceutical formulations | |
| KR100768401B1 (ko) | 무좀방지용 화장료 조성물 | |
| Lemar | Cell death in the human pathogen Candida albicans: effects of garlic (Allium sativum), and garlic constituents allyl alcohol and diallyl disulphide | |
| Bruce | Superficial fungal infections | |
| Huang | Cutaneous effect of immunosuppressive medications | |
| CA2812968A1 (en) | Pharmaceutical formulation containing phenytoin sodium and magnesium stearate | |
| WO2018051363A1 (en) | Antifungal formulations from medicinal plants for vaginal candidiasis | |
| HK1183818B (en) | Oral spray formulations and methods for administration of sildenafil citrate | |
| HK1183818A (en) | Oral spray formulations and methods for administration of sildenafil citrate |